Search

everythinglearnresearchcommunity

for

Search:↓

Gujian oral liquid reduces osteoarthritis symptoms by targeting inflammation.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Treatments for Polycystic Ovary Syndrome (PCOS) focus on reducing symptoms, restoring regular periods, and helping with pregnancy. Common treatments include hormone suppressors, fertility drugs, and insulin-sensitising agents.

Alopecia treatments are improving, but future therapies need to target underlying causes for better results.

Alopecia treatments are improving, but future therapies need to target underlying causes for better results.

Human umbilical cord stem cell vesicles may help treat aging and related diseases.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Microneedle patches could replace injections but need more development for better use in medicine.

Adding a second method to PROTACs could improve cancer treatment.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

Understanding hair growth pathways can lead to better hair loss treatments.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Keratin-based biomaterials are promising for wound healing, drug delivery, and nerve regeneration due to their biodegradability and biocompatibility.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

We now understand more about what causes acne and this could lead to better, more personalized treatments.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Graphene oxide helps deliver a skin healing agent over time, improving skin and hair follicle regeneration.

New treatments for hair loss are being developed using molecular biology.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

A sick foal with Rhodococcus equi pneumonia was successfully treated for multiple complications with targeted therapy and careful monitoring.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.